Your browser doesn't support javascript.
loading
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Willemse, Peter-Paul M; Davis, Niall F; Grivas, Nikolaos; Zattoni, Fabio; Lardas, Michael; Briers, Erik; Cumberbatch, Marcus G; De Santis, Maria; Dell'Oglio, Paolo; Donaldson, James F; Fossati, Nicola; Gandaglia, Giorgio; Gillessen, Silke; Grummet, Jeremy P; Henry, Ann M; Liew, Matthew; MacLennan, Steven; Mason, Malcolm D; Moris, Lisa; Plass, Karin; O'Hanlon, Shane; Omar, Muhammad Imran; Oprea-Lager, Daniela E; Pang, Karl H; Paterson, Catherine C; Ploussard, Guillaume; Rouvière, Olivier; Schoots, Ivo G; Tilki, Derya; van den Bergh, Roderick C N; Van den Broeck, Thomas; van der Kwast, Theodorus H; van der Poel, Henk G; Wiegel, Thomas; Yuan, Cathy Yuhong; Cornford, Philip; Mottet, Nicolas; Lam, Thomas B L.
Afiliación
  • Willemse PM; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: p.m.willemse-3@umcutrecht.nl.
  • Davis NF; Department of Urology, Beaumont and Connolly Hospitals, Dublin, Ireland; Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Grivas N; Department of Urology, G. Hatzikosta General Hospital, Ioannina, Greece.
  • Zattoni F; Urology Unit, Academic Medical Centre Hospital, Udine, Italy.
  • Lardas M; Department of Reconstructive Urology and Surgical Andrology, Metropolitan General, Athens, Greece.
  • Briers E; Patient Advocate, Hasselt, Belgium.
  • Cumberbatch MG; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • De Santis M; Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Medical University of Vienna, Austria.
  • Dell'Oglio P; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Donaldson JF; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Fossati N; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gandaglia G; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland; University of Bern, Bern, Switzerland.
  • Grummet JP; Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.
  • Henry AM; Leeds Cancer Centre, St. James's University Hospital and University of Leeds, Leeds, UK.
  • Liew M; Department of Urology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
  • MacLennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
  • Mason MD; Division of Cancer and Genetics, School of Medicine Cardiff University, Velindre Cancer Centre, Cardiff, UK.
  • Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Plass K; EAU Guidelines Office, Arnhem, The Netherlands.
  • O'Hanlon S; Department of Geriatric Medicine, St Vincent's University Hospital, Dublin, Ireland.
  • Omar MI; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
  • Oprea-Lager DE; Department of Radiology and Nuclear medicine, Amsterdam University Medical Centers, VU Medical Center, Amsterdam, The Netherlands.
  • Pang KH; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Paterson CC; University of Canberra, School of Nursing, Midwifery and Public Health, Canberra, Australia.
  • Ploussard G; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France; Institut Universitaire du Cancer, Toulouse, France.
  • Rouvière O; Department of Radiology, Edouard Herriot Hospital, Lyon, France.
  • Schoots IG; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.
  • van den Bergh RCN; Department of Urology, Antonius Hospital, Utrecht, The Netherlands.
  • Van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • van der Kwast TH; Medicine Program and Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • van der Poel HG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Yuan CY; Department of Medicine, McMaster University, Hamilton, Canada.
  • Cornford P; Department of Urology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
  • Mottet N; Department of Urology, University Hospital, St. Etienne, France.
  • Lam TBL; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
Eur Urol ; 81(4): 337-346, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34980492
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article Pais de publicación: Suiza